Clearance mechanisms of Alzheimer’s amyloid-b peptide: implications for therapeutic design and diagnostic tests
| dc.contributor.author | Bates, K. | |
| dc.contributor.author | Verdile, Giuseppe | |
| dc.contributor.author | Li, Q. | |
| dc.contributor.author | Ames, D. | |
| dc.contributor.author | Hudson, P. | |
| dc.contributor.author | Masters, C. | |
| dc.contributor.author | Martins, R. | |
| dc.date.accessioned | 2017-01-30T11:53:12Z | |
| dc.date.available | 2017-01-30T11:53:12Z | |
| dc.date.created | 2014-11-19T01:13:20Z | |
| dc.date.issued | 2009 | |
| dc.identifier.citation | Bates, K. and Verdile, G. and Li, Q. and Ames, D. and Hudson, P. and Masters, C. and Martins, R. 2009. Clearance mechanisms of Alzheimer’s amyloid-b peptide: implications for therapeutic design and diagnostic tests. Molecular Psychiatry. 14: pp. 469-486. | |
| dc.identifier.uri | http://hdl.handle.net/20.500.11937/15995 | |
| dc.publisher | Nature Publishing Group | |
| dc.title | Clearance mechanisms of Alzheimer’s amyloid-b peptide: implications for therapeutic design and diagnostic tests | |
| dc.type | Journal Article | |
| dcterms.source.volume | 14 | |
| dcterms.source.startPage | 469 | |
| dcterms.source.endPage | 486 | |
| dcterms.source.issn | 1359-4184 | |
| dcterms.source.title | Molecular Psychiatry | |
| curtin.accessStatus | Fulltext not available |